Net Sales (¥1 million)		Gross Profit (¥1 million)

Operating Income (Loss) (¥1 million)		Ordinary Income (Loss) (¥1 million)

Net Income (Loss) (¥1 million)		Cash Flows (¥1 million)

Financial Position (¥1 million)		Return On Equity (ROE) (%)

Capital Expenditures / Depreciation and Amortization (¥1 million)		Research and Development Costs (¥1 million)

Consolidated Results

(¥1 million)

	3/07	3/08	3/09	3/10	3/11
Net Sales  　Domestic Sales  　Overseas Sales	262,239 135,694 126,545	284,218 135,492 148,726	225,789 100,608 125,181	135,979 65,813 70,166	163,153 80,341 82,812
Gross Profit  　Ratio to Net Sales	116,419 44.4%	127,706 44.9%	93,922 41.6%	46,604 34.3%	64,193 39.3%
Operating Income (Loss)  　Ratio to Net Sales	39,088 14.9%	44,939 15.8%	18,701 8.3%	(9,654) -7.1%	4,353 2.7%
Ordinary Income (Loss)  　Ratio to Net Sales	44,491 17.0%	47,705 16.8%	17,559 7.8%	(4,416) -3.2%	6,757 4.1%
Net Income (Loss)  　Ratio to Net Sales	27,506 10.5%	28,337 10.0%	8,488 3.8%	(3,739) -2.7%	2,716 1.7%

Cash Flows

(¥1 million)

	3/07	3/08	3/09	3/10	3/11
Operating Cash Flow	20,975	26,322	11,014	18,213	12,185
Investing Cash Flow	(15,963)	(17,168)	(4,580)	(9,872)	(649)
Free Cash Flows	5,012	9,154	6,434	8,341	11,536

Financial Position

(¥1 million)

	3/07	3/08	3/09	3/10	3/11
Total Assets	545,473	543,535	479,947	468,178	452,792
Net Assets	418,969	425,588	392,636	388,667	375,159
Equity Ratio	76.0%	77.7%	81.3%	82.6%	82.5%

Return On Equity (ROE)

(%)

	3/07	3/08	3/09	3/10	3/11
ROE	6.8	6.8	2.1	-1.0	0.7

Capital Expenditures / Depreciation and Amortization

(¥1 million)

	3/07	3/08	3/09	3/10	3/11
Capital Expenditures	19,094	17,031	15,447	11,579	10,644
Depreciation and Amortization	8,915	10,042	8,576	8,256	7,638

Research and Development Costs

(¥1 million)

	3/07	3/08	3/09	3/10	3/11
Research and Development Costs	6,372	6,916	5,982	5,457	6,304
Ratio to Net Sales	2.4%	2.4%	2.6%	4.0%	3.9%